참고문헌
- Aliprantis, A.O., Ueki, Y., Sulyanto, R., Park, A., Sigrist, K.S., Sharma, S.M., Ostrowski, M.C., Olsen, B.R., and Glimcher, L.H. (2008). NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118, 3775-3789. https://doi.org/10.1172/JCI35711
- Asagiri, M., and Takayanagi, H. (2007). The molecular understanding of osteoclast differentiation. Bone 40, 251-264. https://doi.org/10.1016/j.bone.2006.09.023
- Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E.F., Mak, T.W., Serfling, E., et al. (2005). Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269. https://doi.org/10.1084/jem.20051150
- Boyle, W.J., Simonet, W.S. and Lacey, D.L. (2003). Osteoclast differentiation and activation. Nature. 423, 337-342. https://doi.org/10.1038/nature01658
- Cella, M., Buonsanti, C., Strader, C., Kondo, T., Salmaggi, A., and Colonna, M. (2003). Impaired differentiation of osteoclasts in TREM- 2-deficient individuals. J. Exp. Med. 198, 645-651. https://doi.org/10.1084/jem.20022220
- Chambers, T.J. and Fuller, K. (2011). How are osteoclasts induced to resorb bone? Ann. N Y Acad. Sci. 1240, 1-6. https://doi.org/10.1111/j.1749-6632.2011.06249.x
- Cheng, X., Kinosaki, M., Murali, R., and Greene, M.I. (2003). The TNF receptor superfamily: role in immune inflammation and bone formation. Immunol. Res. 27, 287-294. https://doi.org/10.1385/IR:27:2-3:287
- Choi, H.K., Kang, H.R., Jung, E., Kim, T.E., Lin, J.J. and Lee, S.Y. (2013). Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis. Cell Res. 23, 524-536. https://doi.org/10.1038/cr.2013.33
- Darnay, B.G., Haridas, V., Ni, J., Moore, P.A. and Aggarwal, B.B. (1998). Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c- Jun N-terminal kinase. J. Biol. Chem. 273, 20551-20555. https://doi.org/10.1074/jbc.273.32.20551
- David, J.P., Sabapathy, K., Hoffmann, O., Idarraga, M.H. and Wagner, E.F. (2002). JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115, 4317-4325. https://doi.org/10.1242/jcs.00082
- Dougall, W.C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M.E., Maliszewski, C.R., et al. (1999). RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424. https://doi.org/10.1101/gad.13.18.2412
- Duran, A., Serrano, M., Leitges, M., Flores, J.M., Picard, S., Brown, J.P., Moscat, J., and Diaz-Meco, M.T. (2004). The atypical PKCinteracting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell. 6, 303-309. https://doi.org/10.1016/S1534-5807(03)00403-9
- Faccio, R., Teitelbaum, S.L., Fujikawa, K., Chappel, J., Zallone, A., Tybulewicz, V.L., Ross, F.P., and Swat, W. (2005). Vav3 regulates osteoclast function and bone mass. Nat. Med. 11, 284-290. https://doi.org/10.1038/nm1194
- Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E.W., Brown, K.D., Leonardi, A., Tran, T., Boyce, B.F. and Siebenlist, U. (1997). Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11, 3482-3496. https://doi.org/10.1101/gad.11.24.3482
- Fumoto, T., Takeshita, S., Ito, M., and Ikeda, K. (2014). Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis. J. Bone Miner Res. 29, 830-842. https://doi.org/10.1002/jbmr.2096
- Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl, S81-96. https://doi.org/10.1016/S0092-8674(02)00703-1
- Grigoriadis, A.E., Wang, Z.Q., Cecchini, M.G., Hofstetter, W., Felix, R., Fleisch, H.A., and Wagner, E.F. (1994). c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448. https://doi.org/10.1126/science.7939685
- He, Y., Staser, K., Rhodes, S.D., Liu, Y., Wu, X., Park, S.J., Yuan, J., Yang, X., Li, X., Jiang, L., et al. (2011). Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS One 6, e24780. https://doi.org/10.1371/journal.pone.0024780
- Hogan, P.G., Chen, L., Nardone, J., and Rao, A. (2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232. https://doi.org/10.1101/gad.1102703
- Humphrey, M.B., Daws, M.R., Spusta, S.C., Niemi, E.C., Torchia, J.A., Lanier, L.L., Seaman, W.E., and Nakamura, M.C. (2006). TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J. Bone Miner Res. 21, 237-245.
- Ikeda, F., Nishimura, R., Matsubara, T., Tanaka, S., Inoue, J., Reddy, S.V., Hata, K., Yamashita, K., Hiraga, T., Watanabe, T., et al. (2004). Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114, 475- 484. https://doi.org/10.1172/JCI200419657
- Iotsova, V., Caamano, J., Loy, J., Yang, Y., Lewin, A., and Bravo, R. (1997). Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3, 1285-1289. https://doi.org/10.1038/nm1197-1285
- Jang, H.D., Shin, J.H., Park, D.R., Hong, J.H., Yoon, K., Ko, R., Ko, C.Y., Kim, H.S., Jeong, D., Kim, N., et al. (2011). Inactivation of glycogen synthase kinase-3beta is required for osteoclast differentiation. J. Biol. Chem. 286, 39043-39050. https://doi.org/10.1074/jbc.M111.256768
- Karsenty, G., and Wagner, E.F. (2002). Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2, 389- 406. https://doi.org/10.1016/S1534-5807(02)00157-0
- Kim, N., Takami, M., Rho, J., Josien, R., and Choi, Y. (2002). A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195, 201-209. https://doi.org/10.1084/jem.20011681
- Kim, K., Kim, J.H., Lee, J., Jin, H.M., Kook, H., Kim, K.K., Lee, S.Y., and Kim, N. (2007). MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109, 3253-3259. https://doi.org/10.1182/blood-2006-09-048249
- Kim, K., Lee, S.H., Ha Kim, J., Choi, Y., and Kim, N. (2008). NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22, 176-185. https://doi.org/10.1210/me.2007-0237
- Kim, H., Choi, H.K., Shin, J.H., Kim, K.H., Huh, J.Y., Lee, S.A., Ko, C.Y., Kim, H.S., Shin, H.I., Lee, H.J., et al. (2009). Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J. Clin. Invest. 119, 813-825. https://doi.org/10.1172/JCI36809
- Kobayashi, N., Kadono, Y., Naito, A., Matsumoto, K., Yamamoto, T., Tanaka, S., and Inoue, J. (2001). Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20, 1271-1280. https://doi.org/10.1093/emboj/20.6.1271
- Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004). Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763. https://doi.org/10.1038/nature02444
- Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K. and Takayanagi, H. (2005). NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880-885. https://doi.org/10.1038/nm1270
- Kong, Y.Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999). Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304-309. https://doi.org/10.1038/46303
- Lee, N.K., Choi, Y.G., Baik, J.Y., Han, S.Y., Jeong, D.W., Bae, Y.S., Kim, N., and Lee, S.Y. (2005). A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852- 859. https://doi.org/10.1182/blood-2004-09-3662
- Li, J., Sarosi, I., Yan, X.Q., Morony, S., Capparelli, C., Tan, H.L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000). RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97, 1566-1571. https://doi.org/10.1073/pnas.97.4.1566
- Li, X., Udagawa, N., Itoh, K., Suda, K., Murase, Y., Nishihara, T., Suda, T., and Takahashi, N. (2002). p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143, 3105-3113. https://doi.org/10.1210/endo.143.8.8954
- Lin, J., Lee, D., Choi, Y., and Lee, S.Y. (2015). The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors. Sci. Signal. 8, ra54. https://doi.org/10.1126/scisignal.2005867
- Lomaga, M.A., Yeh, W.C., Sarosi, I., Duncan, G.S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999). TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024. https://doi.org/10.1101/gad.13.8.1015
- Mao, D., Epple, H., Uthgenannt, B., Novack, D.V., and Faccio, R. (2006). PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116, 2869-2879. https://doi.org/10.1172/JCI28775
- Matsumoto, M., Kogawa, M., Wada, S., Takayanagi, H., Tsujimoto, M., Katayama, S., Hisatake, K., and Nogi, Y. (2004). Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279, 45969-45979. https://doi.org/10.1074/jbc.M408795200
- Miyauchi, Y., Ninomiya, K., Miyamoto, H., Sakamoto, A., Iwasaki, R., Hoshi, H., Miyamoto, K., Hao, W., Yoshida, S., Morioka, H., et al. (2010). The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J. Exp. Med. 207, 751-762. https://doi.org/10.1084/jem.20091957
- Mizukami, J., Takaesu, G., Akatsuka, H., Sakurai, H., Ninomiya-Tsuji, J., Matsumoto, K. and Sakurai, N. (2002). Receptor activator of NFkappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell Biol. 22, 992-1000. https://doi.org/10.1128/MCB.22.4.992-1000.2002
- Moon, J.B., Kim, J.H., Kim, K., Youn, B.U., Ko, A., Lee, S.Y., and Kim, N. (2012). Akt induces osteoclast differentiation through regulating the GSK3beta/NFATc1 signaling cascade. J. Immunol. 188, 163-169. https://doi.org/10.4049/jimmunol.1101254
- Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999). Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4, 353-362. https://doi.org/10.1046/j.1365-2443.1999.00265.x
- Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J.Q., Bonewald, L.F., Kodama, T., Wutz, A., Wagner, E.F., et al. (2011). Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234. https://doi.org/10.1038/nm.2452
- Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K. (1999). The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256. https://doi.org/10.1038/18465
- Nishikawa, K., Nakashima, T., Hayashi, M., Fukunaga, T., Kato, S., Kodama, T., Takahashi, S., Calame, K. and Takayanagi, H. (2010). Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl. Acad. Sci. USA 107, 3117-3122. https://doi.org/10.1073/pnas.0912779107
- Oikawa, T., Oyama, M., Kozuka-Hata, H., Uehara, S., Udagawa, N., Saya, H. and Matsuo, K. (2012). Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. J. Cell Biol. 197, 553-568. https://doi.org/10.1083/jcb.201111116
- Park, S.J., Huh, J.E., Shin, J., Park, D.R., Ko, R., Jin, G.R., Seo, D.H., Kim, H.S., Shin, H.I., Oh, G.T., et al. (2016). Sirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation. Sci. Rep. 6, 26186. https://doi.org/10.1038/srep26186
- Putney, J.W., Jr. (2005). Capacitative calcium entry: sensing the calcium stores. J. Cell Biol. 169, 381-382. https://doi.org/10.1083/jcb.200503161
- Sheridan, C.M., Heist, E.K., Beals, C.R., Crabtree, G.R., and Gardner, P. (2002). Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3. J. Biol. Chem. 277, 48664-48676. https://doi.org/10.1074/jbc.M207029200
- Shin, J., Jang, H., Lin, J., and Lee, S.Y. (2014). PKCbeta positively regulates RANKL-induced osteoclastogenesis by inactivating GSK- 3beta. Mol. Cells 37, 747-752. https://doi.org/10.14348/molcells.2014.0220
- Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R.S., et al. (2008). Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132, 794-806. https://doi.org/10.1016/j.cell.2007.12.037
- Taguchi, Y., Gohda, J., Koga, T., Takayanagi, H., and Inoue, J. (2009). A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals. Genes Cells 14, 1331- 1345. https://doi.org/10.1111/j.1365-2443.2009.01351.x
- Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., et al. (2002). Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901. https://doi.org/10.1016/S1534-5807(02)00369-6
- Teitelbaum, S.L. (2000). Bone resorption by osteoclasts. Science 289, 1504-1508. https://doi.org/10.1126/science.289.5484.1504
- Teitelbaum, S.L. and Ross, F.P. (2003). Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649. https://doi.org/10.1038/nrg1122
- Vaananen, H.K., Karhukorpi, E.K., Sundquist, K., Wallmark, B., Roininen, I., Hentunen, T., Tuukkanen, J., and Lakkakorpi, P. (1990). Evidence for the presence of a proton pump of the vacuolar H(+)- ATPase type in the ruffled borders of osteoclasts. J. Cell Biol. 111, 1305-1311. https://doi.org/10.1083/jcb.111.3.1305
- Wada, T., Nakashima, T., Oliveira-dos-Santos, A.J., Gasser, J., Hara, H., Schett, G. and Penninger, J.M. (2005). The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat. Med. 11, 394-399. https://doi.org/10.1038/nm1203
- Wagner, E.F. (2002). Functions of AP1 (Fos/Jun) in bone development. Ann. Rheum. Dis. 61 Suppl 2, ii40-42. https://doi.org/10.1136/ard.61.suppl_2.ii40
- Wang, Z.Q., Ovitt, C., Grigoriadis, A.E., Mohle-Steinlein, U., Ruther, U., and Wagner, E.F. (1992). Bone and haematopoietic defects in mice lacking c-fos. Nature 360, 741-745. https://doi.org/10.1038/360741a0
- Wong, B.R., Josien, R., Lee, S.Y., Vologodskaia, M., Steinman, R.M., and Choi, Y. (1998). The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J. Biol. Chem. 273, 28355-28359. https://doi.org/10.1074/jbc.273.43.28355
- Wong, B.R., Besser, D., Kim, N., Arron, J.R., Vologodskaia, M., Hanafusa, H., and Choi, Y. (1999). TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell. 4, 1041-1049. https://doi.org/10.1016/S1097-2765(00)80232-4
- Xiong, J., Onal, M., Jilka, R.L., Weinstein, R.S., Manolagas, S.C., and O'Brien, C.A. (2011). Matrix-embedded cells control osteoclast formation. Nat. Med. 17, 1235-1241. https://doi.org/10.1038/nm.2448
- Yagi, M., Ninomiya, K., Fujita, N., Suzuki, T., Iwasaki, R., Morita, K., Hosogane, N., Matsuo, K., Toyama, Y., Suda, T., et al. (2007). Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J. Bone Miner Res. 22, 992-1001. https://doi.org/10.1359/jbmr.070401
- Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I.R., Schwarz, E.M., Takeshita, S., Wagner, E.F., Noda, M., Matsuo, K., et al. (2007). NFkappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 282, 18245-18253. https://doi.org/10.1074/jbc.M610701200
- Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597-3602. https://doi.org/10.1073/pnas.95.7.3597
- Ye, H., Arron, J.R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N.K., Segal, D., Dzivenu, O.K., Vologodskaia, M., Yim, M., et al. (2002). Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447. https://doi.org/10.1038/nature00888
- Zaidi, M. (2007). Skeletal remodeling in health and disease. Nat. Med. 13, 791-801. https://doi.org/10.1038/nm1593
- Zhao, B., Takami, M., Yamada, A., Wang, X., Koga, T., Hu, X., Tamura, T., Ozato, K., Choi, Y., Ivashkiv, L.B., et al. (2009). Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med. 15, 1066-1071. https://doi.org/10.1038/nm.2007
- Zou, W., Kitaura, H., Reeve, J., Long, F., Tybulewicz, V.L., Shattil, S.J., Ginsberg, M.H., Ross, F.P., and Teitelbaum, S.L. (2007). Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176, 877-888. https://doi.org/10.1083/jcb.200611083
피인용 문헌
- Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption vol.9, pp.1664-3224, 2018, https://doi.org/10.3389/fimmu.2018.02263
- Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-29257-1
- Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα vol.68, pp.2, 2019, https://doi.org/10.1007/s00011-018-1209-9
- 치자 추출물이 RANKL 유도 파골세포 형성 및 골 흡수에 미치는 영향 vol.38, pp.6, 2017, https://doi.org/10.22246/jikm.2017.38.6.1035
- 치자 추출물이 RANKL 유도 파골세포 형성 및 골 흡수에 미치는 영향 vol.38, pp.6, 2017, https://doi.org/10.22246/jikm.2017.38.6.1035
- Ubiquitin-dependent proteolysis of CXCL7 leads to posterior longitudinal ligament ossification vol.13, pp.5, 2017, https://doi.org/10.1371/journal.pone.0196204
- TRAF6 Distinctly Regulates Hematopoietic Stem and Progenitors at Different Periods of Development in Mice vol.41, pp.8, 2018, https://doi.org/10.14348/molcells.2018.0191
- Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL‐induced NFAT activation and calcium signaling vol.233, pp.11, 2017, https://doi.org/10.1002/jcp.26841
- Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis vol.19, pp.11, 2018, https://doi.org/10.3390/ijms19113698
- Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption vol.46, pp.suppl3, 2018, https://doi.org/10.1080/21691401.2018.1489264
- Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility vol.47, pp.8, 2018, https://doi.org/10.1080/08820139.2018.1552360
- Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals vol.19, pp.None, 2017, https://doi.org/10.1186/s12891-018-2356-4
- Modulating calcium‐mediated NFATc1 and mitogen‐activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption vol.234, pp.1, 2017, https://doi.org/10.1002/jcp.26893
- The application of nanogenerators and piezoelectricity in osteogenesis vol.20, pp.1, 2017, https://doi.org/10.1080/14686996.2019.1693880
- Phospholipase Cγ Signaling in Bone Marrow Stem Cell and Relevant Natural Compounds Therapy vol.14, pp.None, 2019, https://doi.org/10.2174/1574888x14666191107103755
- MicroRNAs: Key Regulators to Understand Osteoclast Differentiation? vol.10, pp.None, 2017, https://doi.org/10.3389/fimmu.2019.00375
- Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss vol.10, pp.None, 2019, https://doi.org/10.3389/fendo.2019.00608
- Tetrandrine enhances the ubiquitination and degradation of Syk through an AhR-c-src-c-Cbl pathway and consequently inhibits osteoclastogenesis and bone destruction in arthritis vol.10, pp.2, 2017, https://doi.org/10.1038/s41419-018-1286-2
- Gene co-expression network analysis identifies BRCC3 as a key regulator in osteogenic differentiation of osteoblasts through a β-catenin signaling dependent pathway vol.22, pp.2, 2017, https://doi.org/10.22038/ijbms.2018.29498.7123
- Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells vol.20, pp.6, 2017, https://doi.org/10.3390/ijms20061439
- Hyperglycemia Induces Osteoclastogenesis and Bone Destruction Through the Activation of Ca2+/Calmodulin-Dependent Protein Kinase II vol.104, pp.4, 2017, https://doi.org/10.1007/s00223-018-0499-9
- Cryptotanshinone inhibits RANKL‐induced osteoclastogenesis by regulating ERK and NF‐κB signaling pathways vol.120, pp.5, 2019, https://doi.org/10.1002/jcb.28008
- G protein‐coupled receptor 119 is involved in RANKL‐induced osteoclast differentiation and fusion vol.234, pp.7, 2017, https://doi.org/10.1002/jcp.27805
- Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases vol.20, pp.14, 2017, https://doi.org/10.3390/ijms20143576
- Benzylideneacetone Derivatives Inhibit Osteoclastogenesis and Activate Osteoblastogenesis Independently Based on Specific Structure-Activity Relationship vol.62, pp.13, 2017, https://doi.org/10.1021/acs.jmedchem.9b00270
- Activation of the Peroxisome Proliferator-Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis vol.71, pp.8, 2017, https://doi.org/10.1002/art.40868
- Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression vol.20, pp.15, 2017, https://doi.org/10.3390/ijms20153792
- Fc-gamma receptors and S100A8/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime? vol.58, pp.8, 2019, https://doi.org/10.1093/rheumatology/kez218
- Fermented Sea Tangle (Laminaria japonica Aresch) Suppresses RANKL-Induced Osteoclastogenesis by Scavenging ROS in RAW 264.7 Cells vol.8, pp.8, 2017, https://doi.org/10.3390/foods8080290
- PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption vol.24, pp.18, 2019, https://doi.org/10.3390/molecules24183346
- Specification of Sprouty2 functions in osteogenesis in in vivo context vol.15, pp.4, 2017, https://doi.org/10.1080/15476278.2019.1656995
- Role of APD-Ribosylation in Bone Health and Disease vol.8, pp.10, 2019, https://doi.org/10.3390/cells8101201
- Ligustilide suppresses RANKL‐induced osteoclastogenesis and bone resorption via inhibition of RANK expression vol.120, pp.11, 2019, https://doi.org/10.1002/jcb.29153
- ST5 Positively Regulates Osteoclastogenesis via Src/Syk/Calcium Signaling Pathways vol.42, pp.11, 2019, https://doi.org/10.14348/molcells.2019.0189
- Tatarinan T, an α‐asarone‐derived lignin, attenuates osteoclastogenesis induced by RANKL via the inhibition of NFATc1/c‐Fos expression vol.43, pp.12, 2019, https://doi.org/10.1002/cbin.11197
- Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment vol.8, pp.12, 2019, https://doi.org/10.3390/jcm8122091
- KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy vol.15, pp.12, 2017, https://doi.org/10.1080/15548627.2019.1596491
- A simple and robust reporter gene assay for measuring the bioactivity of anti-RANKL therapeutic antibodies vol.9, pp.69, 2019, https://doi.org/10.1039/c9ra07328k
- Characterization of Tissue-Engineered Human Periosteum and Allograft Bone Constructs: The Potential of Periosteum in Bone Regenerative Medicine vol.209, pp.2, 2017, https://doi.org/10.1159/000509036
- Local Cellular Responses to Metallic and Ceramic Nanoparticles from Orthopedic Joint Arthroplasty Implants vol.15, pp.None, 2020, https://doi.org/10.2147/ijn.s248848
- Evaluation of Isoflavones as Bone Resorption Inhibitors upon Interactions with Receptor Activator of Nuclear Factor-κB Ligand (RANKL) vol.25, pp.1, 2017, https://doi.org/10.3390/molecules25010206
- Hippuric acid and 3‐(3‐hydroxyphenyl) propionic acid inhibit murine osteoclastogenesis through RANKL‐RANK independent pathway vol.235, pp.1, 2017, https://doi.org/10.1002/jcp.28998
- Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques vol.2020, pp.None, 2017, https://doi.org/10.1155/2020/3721383
- An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision vol.12, pp.None, 2017, https://doi.org/10.1177/1759720x20934277
- Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health vol.2020, pp.None, 2017, https://doi.org/10.1155/2020/4791786
- Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis vol.11, pp.None, 2017, https://doi.org/10.3389/fendo.2020.00430
- Magnoflorine Suppresses MAPK and NF-κB Signaling to Prevent Inflammatory Osteolysis Induced by Titanium Particles In Vivo and Osteoclastogenesis via RANKL In Vitro vol.11, pp.None, 2017, https://doi.org/10.3389/fphar.2020.00389
- The Skeletal-Protecting Action and Mechanisms of Action for Mood-Stabilizing Drug Lithium Chloride: Current Evidence and Future Potential Research Areas vol.11, pp.None, 2017, https://doi.org/10.3389/fphar.2020.00430
- Density and function of actin-microdomains in healthy and NF1 deficient osteoclasts revealed by the combined use of atomic force and stimulated emission depletion microscopy vol.53, pp.1, 2017, https://doi.org/10.1088/1361-6463/ab4838
- Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy vol.8, pp.None, 2017, https://doi.org/10.3389/fcell.2020.00325
- Communications Between Bone Marrow Macrophages and Bone Cells in Bone Remodeling vol.8, pp.None, 2017, https://doi.org/10.3389/fcell.2020.598263
- TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression vol.21, pp.3, 2017, https://doi.org/10.3390/ijms21030800
- METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export vol.21, pp.5, 2017, https://doi.org/10.3390/ijms21051660
- Caldecrin inhibits lipopolysaccharide-induced pro-inflammatory cytokines and M1 macrophage polarization through the immunoreceptor triggering receptor expressed in myeloid cells-2 vol.523, pp.4, 2020, https://doi.org/10.1016/j.bbrc.2020.01.045
- Osthole‐loaded N‐octyl‐O‐sulfonyl chitosan micelles (NSC‐OST) inhibits RANKL‐induced osteoclastogenesis and prevents ovariectomy‐induced bone loss in r vol.24, pp.7, 2020, https://doi.org/10.1111/jcmm.15064
- Effect of TRPV1 Antagonist SC0030, a Potent Painkiller, on RANKL‐mediated Osteoclast Differentiation Involved in Bone Resorption vol.41, pp.4, 2020, https://doi.org/10.1002/bkcs.11992
- Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development vol.5, pp.8, 2017, https://doi.org/10.1172/jci.insight.135446
- Endogenous Collagenases Regulate Osteoclast Fusion vol.10, pp.5, 2017, https://doi.org/10.3390/biom10050705
- Cedrol attenuates collagen-induced arthritis in mice and modulates the inflammatory response in LPS-mediated fibroblast-like synoviocytes vol.11, pp.5, 2017, https://doi.org/10.1039/d0fo00549e
- Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy vol.17, pp.None, 2017, https://doi.org/10.1016/j.omtm.2020.04.010
- The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process vol.9, pp.6, 2017, https://doi.org/10.3390/cells9061552
- Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis vol.32, pp.17, 2017, https://doi.org/10.1089/ars.2019.7879
- Viburnum opulus L. Juice Phenolic Compounds Influence Osteogenic Differentiation in Human Osteosarcoma Saos-2 Cells vol.21, pp.14, 2017, https://doi.org/10.3390/ijms21144909
- Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis vol.40, pp.7, 2017, https://doi.org/10.1042/bsr20194387
- miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene vol.56, pp.7, 2020, https://doi.org/10.1007/s11626-020-00479-w
- Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways vol.24, pp.16, 2017, https://doi.org/10.1111/jcmm.15543
- Surface modification of titanium manufactured through selective laser melting inhibited osteoclast differentiation through mitogen-activated protein kinase signaling pathway vol.35, pp.2, 2017, https://doi.org/10.1177/0885328220920457
- Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL‐induced osteoclastogenesis vol.24, pp.17, 2020, https://doi.org/10.1111/jcmm.15622
- Molecular and Cellular Mechanisms of Arthritis in Children and Adults: New Perspectives on Applied Photobiomodulation vol.21, pp.18, 2020, https://doi.org/10.3390/ijms21186565
- Heterogeneity and Actin Cytoskeleton in Osteoclast and Macrophage Multinucleation vol.21, pp.18, 2017, https://doi.org/10.3390/ijms21186629
- IL-23 induces the expression of pro-osteogenic factors in osteoclasts vol.45, pp.5, 2017, https://doi.org/10.1055/a-1099-9028
- The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL vol.21, pp.20, 2020, https://doi.org/10.3390/ijms21207570
- Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions vol.21, pp.20, 2020, https://doi.org/10.3390/ijms21207597
- Macrophage Polarization and Osteoporosis: A Review vol.12, pp.10, 2017, https://doi.org/10.3390/nu12102999
- NIK inhibitor impairs chronic periodontitis via suppressing non-canonical NF-κB and osteoclastogenesis vol.78, pp.7, 2017, https://doi.org/10.1093/femspd/ftaa045
- N -[2-(4-Acetyl-1-Piperazinyl)Phenyl]-2-(3-Methylphenoxy)Acetamide (NAPMA) Inhibits Osteoclast Differentiation and Protects against Ovariectomy-Induced Osteoporosis vol.25, pp.20, 2017, https://doi.org/10.3390/molecules25204855
- Transcriptomic profiling of feline teeth highlights the role of matrix metalloproteinase 9 (MMP9) in tooth resorption vol.10, pp.1, 2020, https://doi.org/10.1038/s41598-020-75998-3
- Nepetin inhibits osteoclastogenesis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signalling pathway, and autophagy vol.24, pp.24, 2017, https://doi.org/10.1111/jcmm.16055
- Inhibition of MEK/ERK upregulates GSH production and increases RANKL-induced osteoclast differentiation in RAW 264.7 cells vol.54, pp.11, 2017, https://doi.org/10.1080/10715762.2020.1742896
- USF3 modulates osteoporosis risk by targeting WNT16, RANKL, RUNX2, and two GWAS lead SNPs rs2908007 and rs4531631 vol.42, pp.1, 2017, https://doi.org/10.1002/humu.24126
- Isofraxidin Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages Isolated from Sprague-Dawley Rats by Regulating NF-κB/NFAT vol.30, pp.None, 2017, https://doi.org/10.1177/0963689721990321
- Deciphering Myostatin’s Regulatory, Metabolic, and Developmental Influence in Skeletal Diseases vol.12, pp.None, 2021, https://doi.org/10.3389/fgene.2021.662908
- Therapeutic Effect of Matrine on Collagen-Induced Arthritis Rats and Its Regulatory Effect on RANKL and OPG Expression vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/4186102
- Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways vol.11, pp.None, 2017, https://doi.org/10.3389/fphar.2020.596230
- Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway vol.15, pp.None, 2017, https://doi.org/10.2147/dddt.s334421
- Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups vol.12, pp.None, 2017, https://doi.org/10.3389/fimmu.2021.778078
- The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases vol.9, pp.None, 2021, https://doi.org/10.3389/fcell.2021.713254
- ZhiJingSan Inhibits Osteoclastogenesis via Regulating RANKL/NF-κB Signaling Pathway and Ameliorates Bone Erosion in Collagen-Induced Mouse Arthritis vol.12, pp.None, 2017, https://doi.org/10.3389/fphar.2021.693777
- Water Extract of Mentha arvensis L. Attenuates Estrogen Deficiency-Induced Bone Loss by Inhibiting Osteoclast Differentiation vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.719602
- Hydroxy-Safflower Yellow A Alleviates Osteoporosis in Ovariectomized Rat Model by Inhibiting Carbonic Anhydrase 2 Activity vol.12, pp.None, 2017, https://doi.org/10.3389/fphar.2021.734539
- Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.781640
- Inhibitory effects of biochanin A on titanium particle‐induced osteoclast activation and inflammatory bone resorption via NF‐κB and MAPK pathways vol.236, pp.2, 2017, https://doi.org/10.1002/jcp.29948
- The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment vol.476, pp.2, 2017, https://doi.org/10.1007/s11010-020-03920-6
- Myricetin: A review of the most recent research vol.134, pp.None, 2021, https://doi.org/10.1016/j.biopha.2020.111017
- Increased expression of CXCL2 in ACPA‐positive rheumatoid arthritis and its role in osteoclastogenesis vol.203, pp.2, 2017, https://doi.org/10.1111/cei.13527
- Osteoclastogenic Potential of Tissue-Engineered Periosteal Sheet: Effects of Culture Media on the Ability to Recruit Osteoclast Precursors vol.22, pp.4, 2017, https://doi.org/10.3390/ijms22042169
- Deletion of the proton receptor OGR1 in mouse osteoclasts impairs metabolic acidosis-induced bone resorption vol.99, pp.3, 2017, https://doi.org/10.1016/j.kint.2020.10.023
- Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth vol.22, pp.6, 2021, https://doi.org/10.3390/ijms22062911
- Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling vol.19, pp.3, 2017, https://doi.org/10.3390/md19030132
- Correlation between LncRNA Profiles in the Blood Clot Formed on Nano-Scaled Implant Surfaces and Osseointegration vol.11, pp.3, 2017, https://doi.org/10.3390/nano11030674
- SIRT1, a promising regulator of bone homeostasis vol.269, pp.None, 2017, https://doi.org/10.1016/j.lfs.2021.119041
- Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss vol.26, pp.7, 2021, https://doi.org/10.3390/molecules26071886
- Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response vol.53, pp.4, 2021, https://doi.org/10.1038/s12276-021-00596-w
- Salubrinal Alleviates Collagen-Induced Arthritis through Promoting P65 Degradation in Osteoclastogenesis vol.22, pp.7, 2021, https://doi.org/10.3390/ijms22073501
- Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures vol.22, pp.10, 2021, https://doi.org/10.3390/ijms22105232
- Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression vol.42, pp.5, 2021, https://doi.org/10.1038/s41401-020-0477-4
- Zinc Sulfate Stimulates Osteogenic Phenotypes in Periosteum-Derived Cells and Co-Cultures of Periosteum-Derived Cells and THP-1 Cells vol.11, pp.5, 2017, https://doi.org/10.3390/life11050410
- Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus vol.9, pp.5, 2021, https://doi.org/10.3390/microorganisms9051070
- Antimicrobial and enzyme-responsive multi-peptide surfaces for bone-anchored devices vol.125, pp.None, 2017, https://doi.org/10.1016/j.msec.2021.112108
- Harmine targets inhibitor of DNA binding‐2 and activator protein‐1 to promote preosteoclast PDGF‐BB production vol.25, pp.12, 2017, https://doi.org/10.1111/jcmm.16562
- Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling vol.22, pp.12, 2017, https://doi.org/10.3390/ijms22126563
- DNA Hybridization-Based Differential Peptide Display Identified Potential Osteogenic Peptides vol.27, pp.2, 2017, https://doi.org/10.1007/s10989-020-10141-4
- Serum Insufficiency Induces RANKL-Independent Osteoclast Formation during Developing Ischemic ONFH vol.9, pp.6, 2017, https://doi.org/10.3390/biomedicines9060685
- Differential bone remodeling mechanism in hindlimb unloaded rats and hibernating Daurian ground squirrels: a comparison between artificial and natural disuse vol.191, pp.4, 2017, https://doi.org/10.1007/s00360-021-01375-9
- Shaping the bone through iron and iron-related proteins vol.58, pp.3, 2021, https://doi.org/10.1053/j.seminhematol.2021.06.002
- The role of statins in the differentiation and function of bone cells vol.51, pp.7, 2017, https://doi.org/10.1111/eci.13534
- Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats vol.246, pp.15, 2017, https://doi.org/10.1177/15353702211011052
- Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth vol.22, pp.15, 2021, https://doi.org/10.3390/ijms22158225
- Synthesis and Biological Evaluation of C-17-Amino-Substituted Pyrazole-Fused Betulinic Acid Derivatives as Novel Agents for Osteoarthritis Treatment vol.64, pp.18, 2017, https://doi.org/10.1021/acs.jmedchem.1c01019
- A possible way to prevent the progression of bone lesions in multiple myeloma via Src‐homology‐region‐2‐domain‐containing‐phosphatase‐1 activation vol.122, pp.10, 2017, https://doi.org/10.1002/jcb.29949
- Inhibition of NFAM1 suppresses phospho‐SAPK/JNK signaling during osteoclast differentiation and bone resorption vol.122, pp.10, 2017, https://doi.org/10.1002/jcb.30076
- Congenital Metabolic Bone Disorders as a Cause of Bone Fragility vol.22, pp.19, 2017, https://doi.org/10.3390/ijms221910281
- Targeting Probiotics in Rheumatoid Arthritis vol.13, pp.10, 2017, https://doi.org/10.3390/nu13103376
- MiRNAs Expression Profiling in Raw264.7 Macrophages after Nfatc1-Knockdown Elucidates Potential Pathways Involved in Osteoclasts Differentiation vol.10, pp.11, 2017, https://doi.org/10.3390/biology10111080
- The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders vol.22, pp.22, 2017, https://doi.org/10.3390/ijms222212374
- Synergistic Effect of Biphasic Calcium Phosphate and Platelet-Rich Fibrin Attenuate Markers for Inflammation and Osteoclast Differentiation by Suppressing NF-κB/MAPK Signaling Pathway in Chronic vol.26, pp.21, 2017, https://doi.org/10.3390/molecules26216578
- Anti-Osteoporotic Effects of n-trans-Hibiscusamide and Its Derivative Alleviate Ovariectomy-Induced Bone Loss in Mice by Regulating RANKL-Induced Signaling vol.26, pp.22, 2017, https://doi.org/10.3390/molecules26226820
- The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens vol.42, pp.6, 2017, https://doi.org/10.1210/endrev/bnab015
- Parathyroid Hormone in the Regulation of Bone Growth and Resorption in Health and Disease vol.76, pp.5, 2021, https://doi.org/10.15690/vramn1440
- 12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation vol.101, pp.no.pa, 2021, https://doi.org/10.1016/j.intimp.2021.108177
- The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases vol.228, pp.None, 2021, https://doi.org/10.1016/j.pharmthera.2021.107941
- Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases vol.9, pp.1, 2021, https://doi.org/10.1038/s41413-021-00136-2
- Selenoprotein W ensures physiological bone remodeling by preventing hyperactivity of osteoclasts vol.12, pp.1, 2017, https://doi.org/10.1038/s41467-021-22565-7
- Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning vol.19, pp.1, 2017, https://doi.org/10.1186/s12964-021-00727-w
- The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis vol.9, pp.12, 2017, https://doi.org/10.3390/biomedicines9121880
- LIM Kinases in Osteosarcoma Development vol.10, pp.12, 2017, https://doi.org/10.3390/cells10123542
- DANCR Mediates the Rescuing Effects of Sesamin on Postmenopausal Osteoporosis Treatment via Orchestrating Osteogenesis and Osteoclastogenesis vol.13, pp.12, 2017, https://doi.org/10.3390/nu13124455
- FGF19 protects against obesity-induced bone loss by promoting osteogenic differentiation vol.146, pp.None, 2017, https://doi.org/10.1016/j.biopha.2021.112524